Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
MYOthis companyMyomo, Inc.	$1.31	-2.46×	3.34×	0.93×	-3.56×	-1616.4%	65.7%	-35.2%	-38.1%	-136.6%	-46.8%	-42.7%	1.7×	-0.43×	-15.52×	3.3×	0.0%	2	-3.46	2	C
ECORelectroCore, Inc.	$7.56	-2.72×	-22.29×	1.19×	-3.46×	-4106.2%	86.8%	-41.1%	-43.6%	817.2%	-171.0%	-21.7%	-5.5×	-0.2×	-22.29×	1.02×	0.0%	3	-14.75	2	C
HYPDHyperion DeFi, Inc.	$2.59	-0.38×	0.43×	21.88×	-0.45×	-153.6%	62.7%	-2333.4%	-5570.6%	-110.4%	-38.3%	-83.0%	0.21×	-0.05×	-12.18×	2.68×	5.0%	6	-0.75	3	B+
IGCIGC Pharma, Inc.	$0.21	-3.64×	4.08×	21.08×	-3.96×	-225.3%	29.7%	-860.3%	-552.1%	-107.0%	-144.8%	-24.4%	0.15×	-0.11×	0×	0.4×	0.0%	1	-18.6	1	C-
MIRAMIRA Pharmaceuticals, Inc.	$0.59	-1.12×	3.44×	0×	-2.82×	-51.0%	0.0%	0.0%	0.0%	-100.5%	-101.0%	-13.0%	0×	0.61×	0×	15.75×	0.0%	2	320.98	1	C-
MLSSMilestone Scientific Inc.	$0.30	-3.9×	7.97×	2.5×	-4.05×	-405.4%	70.5%	-63.5%	-63.8%	-203.4%	-148.6%	-13.1%	0.36×	0.02×	-222.53×	1.81×	0.0%	3	-19.32	1	C-
Peer median	—	-2.72×	3.44×	2.5×	-3.46×	-225.3%	62.7%	-63.5%	-63.8%	-107.0%	-144.8%	-21.7%	0.15×	-0.05×	-12.18×	1.81×	0.0%	3	-14.75	1	—